Atea Pharmaceuticals, Inc.
AVIR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $77 | $88 | $119 | $65 |
| Short-Term Investments | $252 | $292 | $306 | $390 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $7 | $6 | $8 | $8 |
| Total Curr. Assets | $336 | $386 | $434 | $462 |
| Property Plant & Equip (Net) | $1 | $2 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5 | $4 | $4 | $0 |
| Total NC Assets | $7 | $6 | $6 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $343 | $392 | $440 | $465 |
| Liabilities | – | – | – | – |
| Payables | $4 | $9 | $7 | $4 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $16 | $10 | $14 | $13 |
| Total Curr. Liab. | $20 | $20 | $22 | $19 |
| LT Debt | $0 | $0 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $7 | $7 | $6 | $6 |
| Total NC Liab. | $7 | $7 | $7 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $2 |
| Total Liabilities | $27 | $27 | $29 | $26 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$478 | -$436 | -$398 | -$364 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $793 | $800 | $809 | $803 |
| Total Equity | $316 | $364 | $411 | $439 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $343 | $392 | $440 | $465 |
| Net Debt | -$76 | -$86 | -$118 | -$63 |